GeneTx Biotherapeutics cleared to begin phase I/II study of GTX-102 in Angelman syndrome Jan. 16, 2020
Preliminary findings from phase I study of Spero's SPR-206 support advancement of program Jan. 16, 2020
Sintilimab regimen meets primary endpoint in phase III non-small cell lung cancer trial Jan. 16, 2020
New nonviral nanoparticles are safe and effective for gene therapy in pediatric brain cancer models Jan. 16, 2020
RSS